Camelid News and Research

RSS
How to achieve fast, accurate and reliable quantitation of AAV serotypes

How to achieve fast, accurate and reliable quantitation of AAV serotypes

SARS-CoV-2 variants neutralized by camel nanobodies

SARS-CoV-2 variants neutralized by camel nanobodies

The neutralization potential of nanobodies against SARS-CoV-2

The neutralization potential of nanobodies against SARS-CoV-2

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing

Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing

Camelid nanobody anti-SARS-CoV-2 drug candidates

Camelid nanobody anti-SARS-CoV-2 drug candidates

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Engineering nanobodies to fight against the SARS-CoV-2 virus

Engineering nanobodies to fight against the SARS-CoV-2 virus

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

Nanobody inhalation found to be effective against COVID-19 in hamsters

Nanobody inhalation found to be effective against COVID-19 in hamsters

Antibodies generated by malaria cross-react with SARS-CoV-2

Antibodies generated by malaria cross-react with SARS-CoV-2

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Potent nanobody binds SARS-CoV-2 spike in an extraordinary manner

Potent nanobody binds SARS-CoV-2 spike in an extraordinary manner

Tiny antibodies naturally generated by llamas can be effective against COVID-19

Tiny antibodies naturally generated by llamas can be effective against COVID-19

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Crystal structures of nanobodies could aid the design of COVID-19 therapies

Crystal structures of nanobodies could aid the design of COVID-19 therapies

New publication describes DiosCURE’s multivalent single-chain antibodies to inactivate SARS-CoV-2

New publication describes DiosCURE’s multivalent single-chain antibodies to inactivate SARS-CoV-2

Bispecific sybodies show potential against SARS-CoV-2

Bispecific sybodies show potential against SARS-CoV-2